Study participants and baseline information
SAH, diabetes
HYPERLIPIDEMIA, MOYAMOYA DISEASE, HYPERTENSION, DIABETES
A total of 390 individuals were eventually enrolled in this study, consisting of 88 HCs and 302 MMD patients. Baseline characteristics between the two groups were compared, revealing that MMD patients had a higher prevalence of hypertension, diabetes, hyperlipidemia, smoking, and drinking, as well as higher levels of SBP, DBP, and BMI than HCs (Baseline characteristics between HC and MMD groups.Abbreviations: ALB, albumin; ApoA, apolipoprotein A; ApoB, apolipoprotein B; BMI, body mass index; Cr, creatinine; DBP, diastolic blood pressure; DMG, dimethylglycine; eGFR, estimated glomerular filtration rate; ETA, ethanolamine; GLU, glucose; HC, healthy control; Hcy, homocysteine; HDL‐C, high‐density lipoprotein cholesterol; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; LY, lymphocyte; Met, methionine; MetO, methionine sulfoxide; MMD, moyamoya disease; MONO, monocyte; NEUT, neutrophil; PLT, Platelet; SAH, S‐adenosine homocysteine; SBP, systolic blood pressure; SD, standard deviation; TC, total cholesterol; TG, triglyceride; UA, uric acid; WBC, white blood cell.
Baseline characteristics between HCs and MMD subtypes (ischemic‐type and hemorrhagic‐type) were also compared. Both subtypes showed higher rates of hypertension, hyperlipidemia, smoking, and drinking, as well as higher levels of SBP compared to HCs (Baseline characteristics between HCs and MMD subtypes.
